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Purpose: Mindfulness based interventions (MBIs) are an emerging area of empirical study, not only in positive
psychology, but also in clinical health care. This research aims to synthesize the evidence about whether MBIs
reduce blood pressure (BP) in patients with non-communicable diseases (NCDs).
Methods: Relevant studies were identified via PubMed, the Cochrane Library, Embase and the CINAHL database
between 2009 and 2019. The papers selected focused on mindfulness and the effect of these on the BP of patients
with NCDs. The change in SBP and DBP were meta-analyzed, stratified by type of intervention (Breathing
awareness meditation (BAM), Mindfulness Meditation (MM), and Mindfulness-based Stress Reduction (MBSR).
Results: Fourteen articles met eligibility criteria and were included in the final review. Among the studies using the
type and duration of intervention, systolic BP was reduced after the mindfulness-based stress reduction for 8
weeks (-6.90 mmHg [95% CI: -10.82, -2.97], p < .050), followed by the breathing awareness meditation for 12
weeks (-4.10 mmHg [95% CI: -7.54, -0.66], p < .050) and the mindfulness-based intervention for 8 weeks (-2.69
mmHg [95% CI: -3.90, -1.49], p < .050) whereas diastolic BP was reduced after the mindfulness-based stress
reduction for 8 weeks (-2.45 mmHg [95% CI: -3.74, -1.17], p < .050) and the mindfulness-based intervention for 8
weeks (-2.24 mmHg [95% CI: -3.22, -1.26], p < .050).
Conclusion: MBIs can provide effective alternative therapies to assist in blood pressure reduction for patients with
NCDs.1. Introduction
The World Health Organisation (2018) defines non-communicable
diseases (NCDs) as, non-infectious diseases, caused by combinations of
genetics, physiology, behavioural and environmental factors, that tend
to be of long duration and to progress slowly [1]. They include cancers,
cardiovascular diseases, respiratory diseases and diabetes. The United
Nations has recognized the growing incidence of NCDs as constituting a
global health crisis [2]. Each year, cardiovascular disease accounts for
the deaths of 18 million people, with cancers killing 9 million, respi-
ratory diseases 4 million, and diabetes 1.6 million worldwide [1]. It is
suggested that the stress which these diseases put on the bodies of
sufferers trigger physiological responses induced by the sympathetic
nervous system, causing the body to release cortisol, which increases
blood pressure (BP) [3]. Elevated BP is known as the ‘silent killer’
because it usually has no symptoms, so people are unaware of itskamhang).
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evier Ltd. This is an open access apresence unless BP is routinely measured. Even when individuals are
aware of having high BP, they frequently still ignore it since they do not
experience any symptoms and consequently they may face complica-
tions such as cerebral hemorrhage, stroke and ischemic heart disease
[4]. These conditions causes suffering and economic loss to the indi-
vidual, their family, society and country [4]. Reducing BP can reduce
the risk of developing cardiovascular diseases as well as the risk of
mortality [5]. Treatment for reducing BP includes medication and
health-enhancing lifestyle changes. However, despite advances in BP
treatment, there is still a high percentage of the population who with
high BP and who are unable to control their BP level [6]. In addition,
while antihypertensive drugs are effective, they can produce side effects
such as insomnia, sedation, dry mouth, drowsiness and headaches and
are quite expensive [7]. Many studies found that improved coping with
stress can reduce BP by reducing the sympathetic nervous system's re-
sponses to stress [8].1 April 2020
rticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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traditions integrated with meditation. It can help patients become more
aware of changes in their cognitions and emotions and increase their
levels of self-acceptance, thereby reducing worry and stress. Mindfulness
within positive psychology was developed and used in treatment by
Kabat-Zinn (1979). He defined mindfulness as non-judgmentally paying
attention, on purpose, in the present moment [9]. Mindfulness in-
terventions with patients have become increasingly popular. One pio-
neering example is the Mindfulness-based Stress Reduction (MBSR)
program [10]. The program is made up of 8 sessions over 8 weeks with
regular home practice. It includes sitting and walking meditation and
yoga. In Grossman and colleagues'study, a meta-analysis of 20 studies
utilizing MBSR for patients with diverse conditions such as cancer, sleep
disorders, eating disorders, psoriasis, diabetes and heart diseases re-
ported that MBSR can help individuals cope with physical, psychoso-
matic, psychiatric disorders to improve their well-being [10] and to
reduce the arterial BP on the average 6 mmHg in patients with Type 2
diabetes mellitus [11]. Another program called Breathing Awareness
Meditation (BAM) focuses on diaphragm movements while the patient
breathes deeply and slowly with their eyes closed for 10 min. This helps
calm the sympathetic nervous system and activates the parasympathetic
nervous system simultaneously, leading to a relaxation response [12].
The program includes health education and requires practice at home.
One study reported that a BAM program significantly reduced 24-hour
SBP compared with an education and lifestyle modification program
[13]. Another study found that BAM significantly reduced blood pres-
sures and heart rates of 166 African American participants [14].
Despite the increasing popularity of Mindfulness Based Interventions
(MBIs), there is a lack of consensual knowledge about their effectiveness
in reducing BP in patients with NCDs. This present study aimed to
address this by undertaking a systematic review and meta-analysis to
evaluate the effectiveness of MBIs in BP reduction in patients with NCDs.
2. Methods
The first step involved conducting a preliminary literature review to
determine definitions and get an overview of the research procedures
being used. From this a conceptual framework for the meta-analysis was
obtained that allowed a research synthesis framework to be developed.
The third stage involved undertaking a systematic literature review from
the PubMed, Cochrane Library, Embase, and CINAHL to identify papers
with sufficient information for the research synthesis. To ensure stan-
dardization in the data collection, a data collection form was developed
and piloted using data from 10 published experimental research studies.
After modification it was utilized to record details of the selected
research papers. Next a preliminary data analysis was performed to
calculate descriptive statistics by analyzing the variables related to a) the
research papers b) the researchers and c) the research methodologies.
Finally, the meta-analysis was conducted. To ensure a rigorous approach
to reporting the procedure the PRISMA guidance was followed. Ethical
approval was obtained from the Institutional Review Board of Srina-
kharinwirot University, approval no. SWUEC-264/60.
2.1. Search strategy
We searched the PubMed, Cochrane Library, Embase, and CINAHL
databases for articles published from January 2009 to April 2019. The
search was conducted using the following terms: Population: patients
with NCDs; Intervention: mindfulness; Comparator: standard care OR
usual care OR attention control; Outcome: blood pressure; Study type:
randomized controlled trial OR RCT OR clinical trial and NOT review.
2.2. Selection criteria
The studies had to be published in peer reviewed journals in English
and be accessible and use experimental designs. Mindfulness2interventions were defined as involving the following: the practice of
paying attention, moment-to-moment to promote coping with stress,
illness, and pain with the aim of improving patient health. Studies had to
include quantitative assessment of the effectiveness of the mindfulness
interventions with measurable BP relevant to NCDs with sufficient sta-
tistical information to allow for meta-analysis.
2.3. Data collection and analysis
Study Selection. The PubMed, Cochrane Library, Embase, and
CINAHL databases were selected as they are the largest data bases for
international peer-reviewed research providing comprehensive
coverage of science, medicine, and social sciences which are all rele-
vant inter-disciplinary areas. The focus was on identifying mindfulness
interventions in patients with NCDs published between 2009 and 2019.
The terms included: 1) Mindfulness interventions; 2) BP reported as a
measure; 3) Randomized controlled studies; 4) The most recent studies
(2009–2019); and 5) Publication in English and in a peer-reviewed
journal. Once papers meeting these criteria had been identified, the
authors checked the references in these papers for other papers that
might be relevant. They also used their own knowledge of the
literature.
Data Extraction and Quality Assessment. Data extraction and study
quality assessment were performed by two independent reviewers. Dis-
agreements between the reviewers were resolved by discussion. Data
were collected on the patient characteristics, study design, control group,
intervention characteristics, BP measurement, and results.
To assess the methodological quality of the studies the seven
criteria outlined in the Cochrane Handbook [15], were utilized. These
criteria are assessed as "high", "moderate" or "low" in quality. The seven
criteria are: (1) control of quality: intervention standardization via a
manual or published guidance; (2) adequate randomization occurring
(3) baseline comparability: similarities in the baseline characteristics of
intervention and control groups; (4) completeness of follow-up data;
(5) reporting of dropout rates and their acceptability; (6) blind
assessment of outcomes; (7) an intention-to-treat analysis for handling
missing data. Each criterion was rated as 0 when it was not met or 1
when it is met. Research was evaluated independently by two re-
viewers and scores summated for each. The methodological quality of
study was assessed as being high when six or seven criteria were met
with a follow-up rate of 90%, medium when four to five criteria were
met and low when three or less were met. Any differences were dis-
cussed till agreement was reached.
Data Synthesis. In this research, Statistical analyses were conducted
using the Stata statistical software package (version 12, Stata Corpora-
tion, College Station, Tex). Data were presented as standardized mean
differences (SMDs) and 95% confidence interval. The standardized mean
differences were calculated for each comparison and referred to inter-
vention results compared to control results after intervention. They were
performed by Metan-meta-analysis command. When interpreting the
standardized effect size, a negative effect size represents better results for
intervention than for control group [16].
Identical analysis was used for each condition and outcome. A
random-effects model was used to pool the effect size of all the studies
and an associated 95% confidence intervals (CIs) was estimated. Sensi-
tivity analyses and subgroup analyses were performed. A chi-square test
of heterogeneity p value was used to evaluate the heterogeneity between
the studies. Cochrane's Q test and Higgins' I2 statistics investigated het-
erogeneity. The differences between studies could be seen as the pro-
portion of total variation rather than a sampling error. A heterogeneous
meta-analysis is I2 > 75%, and for this a random-effects model was used.
A I2 value of 0% indicates an absence of dispersion, and larger values
show increasing levels of heterogeneity where 25% can be considered as
low, 50% as moderate and 75% as a high level of heterogeneity,
respectively. We conducted funnel plots and tested their symmetry to
examined publication bias.
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We identified 366 publications in the PubMed, Cochrane Library,
Embase, and CINAHL database between 2009 and 2019. Following this,
the titles and abstracts with duplicates were removed, 189 articles were
identified as being potentially eligible for inclusion. From these, 154
were removed because they were found to have no mindfulness inter-
vention, no NCDs, no appropriate outcomes, no control group and/or not
relevant to the key questions. This left 35 articles potentially eligible for
inclusion. Finally, 21 were removed because they were found to be
conference abstracts and/or to have insufficient information to calculate
the effect sizes. Therefore, 14 articles were included in the meta-analysis.
All of the selected papers reported experimental research that studied
independent variables related to mindfulness interventions and depen-
dent variables including BP in patients with NCDs as given in Figure 1.3.1. Characteristics of included studies
The characteristics of the 14 studies, including the population,
intervention, and outcomes are described in Table 1.
All of the papers aimed to assess the effectiveness of mindfulness
interventions and 10 (71.4%) adopted randomized controlled trial de-
signs. The 14 studies assessed 1,117 patients, of which 593 were in
intervention groups and 482 were in control groups and all studied the
effects of mindfulness interventions on BP. Nine papers (62.3%) were on
patients with cardiovascular disease, followed by three (21.4%) on dia-
betes mellitus, and two (14.3%) on cancer. The inter-rater correlation for
the quality assessment of the studies was considered to be moderate
agreement (kappa ¼ 0.73, Standard Error: 0.15, p  .001) [31]. The
quality scores shown are those agreed upon after discussion. The quality
scoring ranged from 1 to 7. Eight studies were rated as medium quality
and six were high quality.
With random effects meta-analyses, the pooled estimate of the mean
intervention effect on BP was high with significant effects in comparison
to the control groups for SBP (-5.53 mmHg [95% CI: -7.81, -3.25]) and
DBP (-2.13 mmHg [95% CI: -2.97, -1.30]) Heterogeneity was high for
SBP (Q¼ 106.46; p< .001; I2¼ 87.8%) and DBP (Q¼ 24.17; p< .001; I2
¼ 46.2%).
3.2. Subgroup analyses
Comparisons between the intervention and control groups, resulted in
negative effect sizes indicating that BP levels were lower in theFigure 1. Flow diagram
3intervention groups compared with the control groups. The detailed re-
sults are presented in Figure 2.
For systolic BP was reduced after the mindfulness-based stress
reduction for 8 weeks (-6.90 mmHg [95% CI: -10.82, -2.97], p < .050),
followed by the breathing awareness meditation for 12 weeks (-4.10
mmHg [95% CI: -7.54, -0.66], p < .050) and the mindfulness-based
intervention for 8 weeks (-2.69 mmHg [95% CI: -3.90, -1.49], p <
.050) but not after a 5-minute mindful breathing (-5.90 mmHg [95% CI:
-21.17, 9.37], p > .050) and the online mindfulness-based stress reduc-
tion for 12 months (-1.60 mmHg [95% CI: -5.52, 2.32], p > .050). For
diastolic BP was reduced after the mindfulness-based stress reduction for
8 weeks (-2.45 mmHg [95% CI: -3.74, -1.17], p < .050) and the
mindfulness-based intervention for 8 weeks (-2.24mmHg [95% CI: -3.22,
-1.26], p < .050), but not after a 5-minute mindful breathing (-3.50
mmHg [95% CI: -10.11, 3.11], p > .050), the breathing awareness
meditation for 12 weeks (-1.48 mmHg [95% CI: -4.22, -1.26], p > .050),
the online mindfulness-based stress reduction for 12 months (-0.10
mmHg [95% CI: -2.40, 2.20], p > .050).3.3. Publication bias
The Funnel plots were asymmetrically distributed for both systolic
and diastolic BP in Figure 3. Egger's regression intercept suggests that
publication bias is absent for the systolic BP (intercept ¼ -0.45, t¼ -0.22,
p> .050) and for the diastolic BP (intercept¼ 0.12, t¼ 0.46, p> .050). In
a sensitivity analysis in which we excluded the eight trials that using
office BP measurement from the meta-analyses, the overall effect size
remained unchanged in Figure 4.
4. Discussion
There is increasing scientific evidence to support the mindfulness
interventions on BP between 2009 and 2019, which is consistent with an
increasing interest in the study of mindfulness interventions in clinical
treatment in the last few years, both in research and practice. Moreover,
various mindfulness interventions for hypertension have been developed
and applied within the past few years. The rationale of applying the
mindfulness for treatment on reducing BP level was sympathetic activ-
ities reduction, improving the brain function related to attention and
memory, respiratory and circulatory system, and psychological health
related to control of stress and emotions [32, 33]. In addition, research
has consistently shown that the intervention most commonly used in the
studies reviewed was MBSR. This intervention was also found to beof article selection.
Table 1. Characteristics of the studies.
Authors (year) Patient character-istic Design Control group N Ni Nc Intervention (the number of
sessions, duration of intervention)
BP measure-ment Results of Blood Pressure Reduction Quality
assess-ment
1. Blom et al. (2014)
[17]
Patients with unmedicated stage 1
hypertension
Randomized controlled
trial
Wait-list control 87 46 41 Mindfulness-Based Stress
Reduction, (8 sessions,
8 weeks)
24-hour ABP No significant group differences were
found for all ambulatory BP
parameters after the intervention
High
2. Campbell et al.
(2012) [18]
Patients with cancer Quasi-experimental, pre-
and posttest control
group design
Wait-list control 70 39 31 Mindfulness-Based Stress
Reduction, (8 sessions,
8 weeks)
24-hour ABP No significant group differences were
found for BP parameters after the
intervention
Medium
3. Gotink et al.
(2017) [19]
Patients with heart disease Single blinded, pragmatic
RCT
Usual care 324 215 109 Mindfulness-Based Stress
Reduction, (12 sessions,
12 months)
Clinic
BP
Significant group differences were
found for changes in SBP after the
intervention
High
4. Hartmann et al.
(2012) [20]
Patients at high risk of diabetes
complications
Randomized controlled
trial
Treatment-as-usual
group (TAU)
110 53 57 Mindfulness-Based Stress
Reduction, (8 sessions, 8 weeks)
24-hour ABP Significant group differences were
found for changes in DBP after the
intervention
High
5. Hughes et al.
(2013) [21]
Patients with unmedicated
prehypertension
Randomized controlled
trial
Progressive muscle
relaxation training
(PMR).
56 28 28 Mindfulness-Based Stress
Reduction, (8 sessions, 8 weeks)
24-hour ABP Significant group differences were
found for changes in SBP and DBP after
the intervention
High
6. Kumar et al.
(2017) [22]
Patients with type-2 diabetes Randomized Pilot Study Control group 40 20 20 Mindfulness-Based Stress
Reduction, (8 sessions, 8 weeks)
Clinic BP Significant group differences were
found for changes in SBP after the
intervention
No significant group differences for
changes in DBP
Medium
7. Momeni et al.
(2016) [23]
Patients with cardiovascular
disease
Single-blind randomized
controlled trial
Control group 60 30 30 Mindfulness-Based Stress
Reduction, (8 sessions, 8 weeks)
Clinic BP Significant group differences were
found for changes in SBP after the
intervention
High
8. Nejati et al. (2015)
[24]
Patients with hypertension Quasi-experimental study
with a control group
Yoga training 30 15 15 Mindfulness-Based Stress
Reduction, (8 sessions, 8 weeks)
Clinic BP Significant group differences were
found for changes in SBP DBP after the
intervention
Medium
9.Ng et al. (2016)
[25]
Patients with cancer Randomized controlled
trial
The normal listening
group
60 30 30 Breathing awareness meditation
(1 sessions, 1 day)
Clinic BP Significant group differences were
found for changes in SBP and DBP after
the intervention
Medium
10. Palta et al. (2012)
[26]
Low-Income African-American
Older Adults with
cardiovascular disease
Prospective randomized
controlled trial
Social support 20 12 8 Mindfulness-Based Stress
Reduction, (8 sessions, 8 weeks)
Clinic BP Significant group differences were
found for changes in SBP and DBP after
the intervention
Medium
11. Parswani et al.
(2013) [27]
Patients with cardiovascular
disease
Randomized controlled
trial
Treatment-as-usual
group (TAU)
30 15 15 Mindfulness-Based Stress
Reduction, (8 sessions, 8 weeks)
Clinic BP Significant group differences were
found for all BP parameters after the
intervention
Medium
12. Pearson et al.
(2018) [28]
Patients with diabetes Randomized controlled
trial
Usual care 67 31 36 Mindfulness-based intervention (8
sessions, 8 weeks)
Clinic BP Significant group differences were
found for changes in SBP after the
intervention
Medium
13. Ponte Marquez
et al. (2019) [29]
Patients with arterial hypertension Randomized controlled
trial
Health education 42 24 18 Mindfulness-based intervention (8
sessions, 8 weeks)
24-hour ABP Significant group differences were
found for changes in SBP and DBP after
the intervention
High
14. Wright et al.
(2011) [30]
African American Adolescents
with hypertension
Randomized single-blind Health education 121 35 44 Breathing awareness meditation,
(12 sessions, 12 weeks)
24-hour ABP Significant group differences were
found for changes in SBP after the
intervention
Medium
Design (RCT, randomized controlled trial; QE, quasi experimental design); N, total number of subjects in this study; Ni, number of subjects in the intervention group; Nc, number of subjects in the control group; BP
measurement (24-h ABP, 24-h ambulatory blood pressure; Clinic BP, clinic blood pressure).
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Figure 2. Forest plot showing effects of mindfulness intervention on blood pressure.
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Figure 3. Diagnosis of publication bias in the combined effect on blood pressure.
U. Intarakamhang et al. Heliyon 6 (2020) e03834associated with the greatest reductions in both diastolic and systolic BP.
Delivery time for the intervention ranging from eight to twelve sessions
although eight sessions delivered weekly was the most frequently found
pattern. In terms of quality six of the MBSR studies were judged to be of
high quality using the Cochrane criteria and this adds to the confidence
with which these results can be accepted. Two studies used BAM but
intervention descriptions lacked some detail resulting in both studies6being ranked as of medium quality. Despite this, the BAM interventions
did produce significant reductions in BP in patients with NCDs. For sys-
tolic BP, the second highest reduction was reported, while for diastolic
BP it reported the lowest reduction of the three interventions, although it
was still statistically significant. Again two studies used MM as the
intervention. One study was judged to be of high quality while one was of
medium quality. For diastolic BP, the reduction reported was greater
Figure 4. Forest plot showing a sensitivity analysis a sensitivity analysis by removing studies based on office BP.
U. Intarakamhang et al. Heliyon 6 (2020) e03834than for the BAM intervention but it was lowest for systolic BP although
still statistically significant.
These results indicate that mindfulness interventions appear to be
effective at reducing BP in patients suffering from a range of NCDs.
Theoretically, it is suggested patients with NCDs may benefit from
mindfulness practice through various pathways. Firstly, psychological7symptoms may be modulated through the self-regulation of attention.
Thus stress and anxiety may be better controlled. Secondly, mindfulness
has been shown to promote body awareness, relaxation and cognitive
coping processes that are associated with parasympathetic activation,
that have been shown to reduce BP [34]. From this review it appears that
effective interventions can be delivered individually or in groups and can
U. Intarakamhang et al. Heliyon 6 (2020) e03834help enhance wellbeing [34]. The resultant more positive attitudes re-
ported by participants had positive effects on their wellbeing [35]. They
also show that mindfulness interventions can help patients apply lifestyle
modifications more effectively to reduce and maintain reductions in their
BP [36].
There is physiological evidence demonstrating that regular mindful-
ness practice, especially deep meditation, activates the autonomic ner-
vous system to release endorphins and serotonin which leads to
norepinephrine and parasympathetic responses [37] and lowers cortisol
levels which can help reduce the symptoms of NCDs and make our bodies
and minds work more effectively [38].
While this review has identified and examined three different mind-
fulness interventions delivered in clinical settings, the findings in support
of the effectiveness of mindfulness is in line with other views of different
types of mediation or specific groups of patients [39]. One review
examined the found transcendental and non-transcendental meditation
to be effective in the reducing BP [14]. Another review reported that
mindfulness-based intervention effectively reduced BP inpatients with
vascular disease by reducing levels of albuminuria and stress homones
[40].
5. Conclusion
The decision to include only research papers that were published in
international research journals, did limit the size of data sources. The
gray literature was not searched. This loss of data may bias the findings in
that studies with non-significant results are less likely to be published,
this increasing selection bias. It is of concern when reviewing literature
such as this to observe that many experimental research studies do not
present sufficient statistical detail to allow meta-analyses to be under-
taken. Despite these limitations, clear support for the effectiveness of
mindfulness interventions in reducing BP in patients suffering from NCDs
is emerging.
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